GLOBUS MEDICAL INC
GMED Real Time Price USDRecent trades of GMED by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in GMED holdings by institutional investors
Quarterly net insider trading by GMED's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$10,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$10,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$10,000 Apr 20, 2020 Issue: Health Issues Medicare/Medicaid
-
$10,000 Jan 21, 2020 Issue: Health Issues Medicare/Medicaid
-
$20,000 Oct 21, 2019 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jul 22, 2019 Issue: Health Issues Medicare/Medicaid
-
$10,000 Jan 22, 2019 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$10,000 Oct 22, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$10,000 Jul 20, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$10,000 Oct 20, 2017 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$10,000 Jul 20, 2017 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$10,000 Apr 20, 2017 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$10,000 Jan 23, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$10,000 Oct 20, 2016 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$10,000 Jul 20, 2016 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$10,000 Apr 20, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$10,000 Jan 19, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$10,000 Oct 20, 2015 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$10,000 Apr 21, 2014 Issue: Health Issues Medicare/Medicaid
-
$10,000 Jan 21, 2014 Issue: Health Issues Medicare/Medicaid
-
$10,000 Oct 21, 2013 Issue: Health Issues Medicare/Medicaid
-
$10,000 Jul 21, 2013 Issue: Health Issues Medicare/Medicaid
-
$10,000 Apr 18, 2013 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jan 22, 2013 Issue: Medicare/Medicaid Health Issues
-
$20,000 Oct 22, 2012 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jul 20, 2012 Issue: Health Issues Medicare/Medicaid
-
$20,000 Apr 19, 2012 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jan 20, 2012 Issue: Health Issues Medicare/Medicaid
-
$10,000 Oct 20, 2011 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jul 20, 2011 Issue: Medicare/Medicaid Health Issues
-
$10,000 Jul 21, 2008 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Apr 21, 2008 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
GMED Estimated quarterly lobbying spending
GMED Revenue by Segment or Geography
New GMED patent grants
Federal grants, loans, and purchases
- $25,030 2025-09-10 00:00:00 Agency: Department of Defense
- $7,854 2025-09-09 00:00:00 Agency: Department of Defense
- $16,280 2025-09-09 00:00:00 Agency: Department of Defense
- $6,528 2025-09-08 00:00:00 Agency: Department of Defense
- $2,156 2025-09-05 00:00:00 Agency: Department of Defense
- $14,669 2025-09-05 00:00:00 Agency: Department of Defense
- $10,414 2025-09-05 00:00:00 Agency: Department of Defense
- $14,668 2025-09-02 00:00:00 Agency: Department of Defense
- $9,927 2025-09-02 00:00:00 Agency: Department of Defense
- $11,382 2025-09-02 00:00:00 Agency: Department of Defense
- $275 2025-09-02 00:00:00 Agency: Department of Defense
- $6,181 2025-09-02 00:00:00 Agency: Department of Defense
- $9,927 2025-08-27 00:00:00 Agency: Department of Defense
- $7,854 2025-08-25 00:00:00 Agency: Department of Defense
- $14,025 2025-08-15 00:00:00 Agency: Department of Defense
- $44,763 2025-08-14 00:00:00 Agency: Department of Defense
- $6,300 2025-08-13 00:00:00 Agency: Department of Defense
- $34,092 2025-08-05 00:00:00 Agency: Department of Defense
- $20,058 2025-08-04 00:00:00 Agency: Department of Defense
- $35,227 2025-07-30 00:00:00 Agency: Department of Defense
- $275 2025-07-24 00:00:00 Agency: Department of Defense
- $14,658 2025-07-24 00:00:00 Agency: Department of Defense
- $9,047 2025-07-21 00:00:00 Agency: Department of Defense
- $70,431 2025-07-21 00:00:00 Agency: Department of Defense
- $12,425 2025-07-17 00:00:00 Agency: Department of Defense
- $43,117 2025-03-27 00:00:00 Agency: Department of Veterans Affairs
- $73,899 2025-01-03 00:00:00 Agency: Department of Veterans Affairs
- $15,278 2024-12-19 00:00:00 Agency: Department of Veterans Affairs
- $18,241 2024-12-11 00:00:00 Agency: Department of Veterans Affairs
- $16,492 2024-11-08 00:00:00 Agency: Department of Veterans Affairs
- $34,652 2024-11-08 00:00:00 Agency: Department of Veterans Affairs
- $17,982 2024-10-31 00:00:00 Agency: Department of Veterans Affairs
- $31,658 2024-10-22 00:00:00 Agency: Department of Veterans Affairs
- $28,172 2024-10-04 00:00:00 Agency: Department of Veterans Affairs
- $41,048 2024-09-30 00:00:00 Agency: Department of Veterans Affairs
- $35,532 2024-06-07 00:00:00 Agency: Department of Veterans Affairs
- $10,978 2024-05-15 00:00:00 Agency: Department of Veterans Affairs
- $15,295 2024-05-14 00:00:00 Agency: Department of Veterans Affairs
- $14,092 2024-05-10 00:00:00 Agency: Department of Veterans Affairs
- $11,023 2024-05-10 00:00:00 Agency: Department of Veterans Affairs
- $12,888 2024-05-10 00:00:00 Agency: Department of Veterans Affairs
- $13,844 2024-05-03 00:00:00 Agency: Department of Veterans Affairs
- $50,905 2024-05-01 00:00:00 Agency: Department of Veterans Affairs
- $22,537 2024-04-25 00:00:00 Agency: Department of Veterans Affairs
- $22,910 2024-04-24 00:00:00 Agency: Department of Veterans Affairs
- $20,900 2024-04-23 00:00:00 Agency: Department of Veterans Affairs
- $10,379 2024-04-22 00:00:00 Agency: Department of Veterans Affairs
- $34,269 2024-04-12 00:00:00 Agency: Department of Veterans Affairs
- $17,342 2024-04-03 00:00:00 Agency: Department of Veterans Affairs
- $12,032 2024-04-01 00:00:00 Agency: Department of Veterans Affairs
Estimated quarterly amount awarded to GMED from public contracts
Recent insights relating to GMED
Recent picks made for GMED stock on CNBC
ETFs with the largest estimated holdings in GMED
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $GMED stock a Buy, Sell, or Hold?
- What is the price target for $GMED stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $GMED stock?
- Who owns the most shares of $GMED stock?
- What funds own $GMED stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GMED Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
- Address Audubon, PA
- Market Cap 11.6 billion
- Employees 5,300
- Industrial Classification Surgical & Medical Instruments & Apparatus